Production and Characterization of Monoclonal Antibodies to Human Sclerostin

被引:3
作者
Craig, Theodore A. [1 ]
Sommer, Stacy L. [1 ]
Beito, Thomas G. [2 ]
Kumar, Rajiv [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA
来源
HYBRIDOMA | 2009年 / 28卷 / 05期
关键词
BONE MORPHOGENETIC PROTEIN; IONIZATION MASS-SPECTROMETRY; METAL-BINDING PROPERTIES; VAN-BUCHEM-DISEASE; CHEMICAL-SYNTHESIS; INHIBITORY-ACTION; BMP ANTAGONIST; SOST GENE; WNT; DELETION;
D O I
10.1089/hyb.2009.0036
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
We developed and characterized monoclonal antibodies directed against the amino-terminal and carboxyterminal regions of human and mouse sclerostin (scl). Amino-terminal and carboxy-terminal scl peptides with limited homology to scl domain-containing protein-1 were synthesized using f-moc chemistry. The peptides were conjugated to keyhole limpet hemocyanin and the conjugates were used for immunization of mice. Monoclonal antibodies were obtained and characterized using bacterially expressed and insect cell-expressed recombinant scl. The amino-terminal (IgG 2aK) and carboxy-terminal (IgG 2bK) antibodies bound bioactive sclerostin that was expressed in an insect-cell expression system with dissociation constants in the nanomolar range. The antibodies are potentially useful agents that can be used for modulating sclerostin bioactivity.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 31 条
[1]
Ausubel FM., 2006, Current Protocols in Molecular Biology
[2]
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease [J].
Balemans, W ;
Patel, N ;
Ebeling, M ;
Van Hul, E ;
Wuyts, W ;
Lacza, C ;
Dioszegi, M ;
Dikkers, FG ;
Hildering, P ;
Willems, PJ ;
Verheij, JBGM ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (02) :91-97
[3]
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) [J].
Balemans, W ;
Ebeling, M ;
Patel, N ;
Van Hul, E ;
Olson, P ;
Dioszegi, M ;
Lacza, C ;
Wuyts, W ;
Van den Ende, J ;
Willems, P ;
Paes-Alves, AF ;
Hill, S ;
Bueno, M ;
Ramos, FJ ;
Tacconi, P ;
Dikkers, FG ;
Stratakis, C ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :537-543
[4]
Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton [J].
Baron, Roland ;
Rawadi, Georges .
ENDOCRINOLOGY, 2007, 148 (06) :2635-2643
[5]
Biological activity of FGF-23 fragments [J].
Berndt, Theresa J. ;
Craig, Theodore A. ;
McCormick, Daniel J. ;
Lanske, Beate ;
Sitara, Despina ;
Razzaque, Mohammed S. ;
Pragnell, Marlon ;
Bowe, Ann E. ;
O'Brien, Stephen P. ;
Schiavi, Susan C. ;
Kumar, Rajiv .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2007, 454 (04) :615-623
[6]
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation [J].
Bezooijen, RL ;
ten Dijke, P ;
Papapoulos, SE ;
Löwik, CWGM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (03) :319-327
[7]
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein [J].
Brunkow, ME ;
Gardner, JC ;
Van Ness, J ;
Paeper, BW ;
Kovacevich, BR ;
Proll, S ;
Skonier, JE ;
Zhao, L ;
Sabo, PJ ;
Fu, YH ;
Alisch, RS ;
Gillett, L ;
Colbert, T ;
Tacconi, P ;
Galas, D ;
Hamersma, H ;
Beighton, P ;
Mulligan, JT .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :577-589
[8]
Caruthers M H, 1983, Gene Amplif Anal, V3, P1
[9]
CARUTHERS MH, 1987, METHOD ENZYMOL, V154, P287
[10]
The metal-binding properties of DREAM - Evidence for calcium-mediated changes in DREAM structure [J].
Craig, TA ;
Benson, LM ;
Venyaminov, SY ;
Klimtchuk, ES ;
Bajzer, Z ;
Prendergast, FG ;
Naylor, S ;
Kumar, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10955-10966